Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.Cell Reports|May 3, 2018
Mutant IDH1 Promotes Glioma Formation In VivoBeatrice Philip, Diana X Yu, Mark R Silvis, et al.Journal of the American Chemical Society|April 1, 2026
Manganese-Templated Nontrivial Structures for MRI and TherapyFarah Benyettou, Thirumurugan Prakasam, Mostafa Khair, et al.Journal of the National Cancer Institute|April 17, 2018
A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant MelanomaCraig C Teerlink, Chad Huff, Jeff Stevens, et al.Melanoma Research|August 12, 2017
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysisLaura J Gardner, Morgan Ward, Robert H I Andtbacka, et al.Molecular Cancer Research : MCR|May 30, 2019
AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain MetastasisDavid A Kircher, Kirby A Trombetti, Mark R Silvis, et al.Oncogene|April 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistanceJunhua Wang, Yinshen Wee, Thomas Jacob, et al.Molecular Cancer Therapeutics|November 6, 2023
Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR SuppressionGennie L Parkman, Tursun Turapov, David A Kircher, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.Pageof 7